← Back to Clinical Trials
Recruiting NCT07434219

NCT07434219 A Group Based Psychoeducational Intervention for Partners of Child Sexual Abuse Material Offenders.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07434219
Status Recruiting
Phase —
Sponsor Region Stockholm
Condition Partner
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-08-25
Primary Completion 2027-12-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
A Group Based Psychoeducational Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-08-25 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The overall aim of this feasibility study is to investigate the clinical characteristics of female partners of male child sexual abuse material (CSAM) offenders and to evaluate the feasibility of a novel psychoeducational group intervention designed to address their specific needs. The main questions it aims to answer are: 1. What are the clinical characteristics of female partners of male CSAM offenders? 2. Is a psychoeducational group intervention for female partners of male CSAM offenders feasible? 3. Does a psychoeducational group intervention for female partners of male CSAM offenders provide any indication of effectiveness? Feasibility will be assessed in terms of 1) recruitment, time from recruitment to offered intervention and completed sessions 2) expectancy of treatment improvement, credibility, and satisfaction 3) acceptability and relevance 4) occurrence of negative effects 5) changes in depression- and anxiety symptoms and psychological well-being 6) changes in daily functioning.

Eligibility Criteria

Inclusion Criteria: * Female partners of male CSAM offenders * A score of ≥ 3 points on the General Health Questionnaire 12 (GHQ-12) at screening and an affirmative response to the follow-up question: Do you feel that your reduced psychological well-being is primarily related to your partner's CSAM offenses? * Ability to understand spoken and written Swedish * Willingness to participate in the intervention * Signed written informed consent form. Exclusion Criteria: * The partner has committed hands-on sexual offenses against children * Presence of a severe mental disorder (e.g., psychosis or major depression) requiring immediate treatment 8) Psychological or cognitive conditions that could compromise participant safety or study integrity (e.g., intellectual disability).

Contact & Investigator

Central Contact

Ulrika Akerstedt

✉ ulrika.akerstedt@ki.se

📞 +46812373200

Frequently Asked Questions

Who can join the NCT07434219 clinical trial?

This trial is open to female participants only, aged 18 Years or older, studying Partner. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07434219 currently recruiting?

Yes, NCT07434219 is actively recruiting participants. Contact the research team at ulrika.akerstedt@ki.se for enrollment information.

Where is the NCT07434219 trial being conducted?

This trial is being conducted at Stockholm, Sweden.

Who is sponsoring the NCT07434219 clinical trial?

NCT07434219 is sponsored by Region Stockholm. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology